Cantabio Pharmaceuticals
Pre-clinicalCANTABio’s research is focused on reducing the harmful effects of biochemical stress, preventing and slowing resulting diseases through developing novel disease modifying therapeutics for neurodegeneration and metabolic conditions
Founded
2015
Focus
Small Molecules
About
CANTABio’s research is focused on reducing the harmful effects of biochemical stress, preventing and slowing resulting diseases through developing novel disease modifying therapeutics for neurodegeneration and metabolic conditions
Funding History
2Total raised: $3M
Grant$500KHungarian National Research, Development and Innovation OfficeJun 15, 2019
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationBudapest, Hungary
StagePre-clinical
Contact
SIMILAR COMPANIES
BioTalentum
Pre-clinical · Gödöllő
LipidArt
Pre-clinical · Budapest
PannonPharma
Pre-clinical · Budapest
Fluart Innovative Vaccines
Pre-clinical · Budapest
Genetic Immunity
Pre-clinical · Budapest
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile